Literature DB >> 28714448

Theoretical to Tangible: Creating a Measure of Self-Advocacy for Female Cancer Survivors.

Teresa L Hagan1, Susan Cohen, Clement Stone, Heidi Donovan.   

Abstract

BACKGROUND AND
PURPOSE: Self-advocacy is well appreciated but poorly defined concept in oncology.
METHODS: The development of the Female Self-Advocacy in Cancer Survivorship (FSACS) Scale's theoretical underpinnings and item development led to evaluations of the measure's content validity and reliability.
RESULTS: The construct of self-advocacy contains 3 subdimensions with 57 Likert-type self-report items. Content validity results (S-CVI = 0.81 and S-CVI/UA = 0.83) indicated strong relevancy of items. Reliability results for each of the 3 subdimensions supported the consistency of the FSACS Scale scores, with strong internal consistency (Cronbach's alphas = .88, .81, and .90) and test-retest reliability (PPMC r = .85, .97, and .88).
CONCLUSIONS: The FSACS Scale captures the construct of self-advocacy, and its scores show strong reliability.

Entities:  

Mesh:

Year:  2016        PMID: 28714448      PMCID: PMC5514617          DOI: 10.1891/1061-3749.24.3.428

Source DB:  PubMed          Journal:  J Nurs Meas        ISSN: 1061-3749


  15 in total

1.  Focus groups in psychological assessment: enhancing content validity by consulting members of the target population.

Authors:  Dawne S Vogt; Daniel W King; Lynda A King
Journal:  Psychol Assess       Date:  2004-09

2.  The content validity index: are you sure you know what's being reported? Critique and recommendations.

Authors:  Denise F Polit; Cheryl Tatano Beck
Journal:  Res Nurs Health       Date:  2006-10       Impact factor: 2.228

3.  The patient self-advocacy scale: measuring patient involvement in health care decision-making interactions.

Authors:  D E Brashers; S M Haas; J L Neidig
Journal:  Health Commun       Date:  1999

4.  The Institute of Medicine report on high-quality cancer care: implications for oncology nursing.

Authors:  Betty Ferrell; Mary S McCabe; Laura Levit
Journal:  Oncol Nurs Forum       Date:  2013-11       Impact factor: 2.172

Review 5.  Selection and use of content experts for instrument development.

Authors:  J S Grant; L L Davis
Journal:  Res Nurs Health       Date:  1997-06       Impact factor: 2.228

6.  Evaluating quality-of-life and health status instruments: development of scientific review criteria.

Authors:  K N Lohr; N K Aaronson; J Alonso; M A Burnam; D L Patrick; E B Perrin; J S Roberts
Journal:  Clin Ther       Date:  1996 Sep-Oct       Impact factor: 3.393

7.  Self-advocacy training for cancer survivors. The Cancer Survival Toolbox.

Authors:  K Walsh-Burke; C Marcusen
Journal:  Cancer Pract       Date:  1999 Nov-Dec

8.  Ovarian cancer survivors' experiences of self-advocacy: a focus group study.

Authors:  Teresa L Hagan; Heidi S Donovan
Journal:  Oncol Nurs Forum       Date:  2013-03       Impact factor: 2.172

9.  Measurement of self-advocacy in cancer patients and survivors.

Authors:  Carol J Hermansen-Kobulnicky
Journal:  Support Care Cancer       Date:  2008-04-02       Impact factor: 3.603

Review 10.  Self-advocacy and cancer: a concept analysis.

Authors:  Teresa L Hagan; Heidi S Donovan
Journal:  J Adv Nurs       Date:  2013-01-24       Impact factor: 3.187

View more
  3 in total

1.  "I pretty much followed the law, and there weren't any decisions to make": A qualitative study of self-advocacy experiences of men with cancer.

Authors:  Teresa Hagan Thomas; Makenna L Hadley; Marci Lee Nilsen
Journal:  Nurs Health Sci       Date:  2021-12-26       Impact factor: 2.214

2.  The Female Self-Advocacy in Cancer Survivorship Scale: A validation study.

Authors:  Teresa L Hagan; Susan M Cohen; Margaret Q Rosenzweig; Kristin Zorn; Clement A Stone; Heidi S Donovan
Journal:  J Adv Nurs       Date:  2017-12-11       Impact factor: 3.187

Review 3.  A Conceptual Framework of Self-advocacy in Women With Cancer.

Authors:  Teresa H Thomas; Heidi S Donovan; Margaret Q Rosenzweig; Catherine M Bender; Yael Schenker
Journal:  ANS Adv Nurs Sci       Date:  2021 Jan-Mar 01       Impact factor: 2.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.